Delivery Order SPE2DB20D7059-SPE2DB25FGSM4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 18 mg capsules (30-count) on August 12, 2025, with a ceiling value of $1,569.60 and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The place of performance is the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,096.92. This competitively awarded, firm fixed-price delivery order is non-set-aside and is scheduled for completion by September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 40 mg capsules (30-count) valued at $1,036.01, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a ceiling value of $1,535.40. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and was awarded without set-aside restrictions through competitive procurement. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30 units, with a contract ceiling value of $2,326.72. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded on a non-set-aside, competitive basis. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,265.16 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30. The contract utilizes firm fixed price pricing and carries an ultimate completion date of August 26, 2025. This non-set-aside competitive award will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Atomoxetine is a non-stimulant medication used primarily in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a contract value of $1,935.72. This non-set-aside, competitively awarded delivery order represents a firm fixed-price transaction with an ultimate completion date of August 25, 2025. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $1,453.90 for the supply of Atomoxetine HCL 10 mg capsules (30-count units). This award, issued on July 31, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, to be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Atomoxetine HCL 40 mg capsules (30-count packages) with a ceiling value of $4,835.87 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order with a completion date of September 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Atomoxetine is a selective...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,505.60 to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 40 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atomoxetine is a...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGSM4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,007.00 to AmerisourceBergen Drug Corp for Atomoxetine HCL 80 mg capsules (30-count units) with a firm fixed price structure. The award, issued on September 19, 2025, is set to be completed by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside contract with no small business restrictions. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a wide array of medications and medical supplies to support military healthcare systems globally, including support for the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, demonstrates significant capability in fulfilling federal medical procurement requirements across multiple therapeutic categories through its extensive portfolio of competitive contract awards with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/19/25 |